Livivos
Livivos' LiverScope® offers instant, accurate liver disease diagnostics, aiding clinical trials, patient care, and prevention.
Founded
2018Livivos' LiverScope® offers instant, accurate liver disease diagnostics, aiding clinical trials, patient care, and prevention.
Founded with the mission to revolutionize liver disease diagnostics, Livivos aims to democratize healthcare through its innovative technology platform. The company's flagship product, LiverScope®, provides instant and accurate liver disease diagnostics, addressing critical needs in pharmaceutical clinical trials, post-market monitoring, patient triage, and preventive medicine. Livivos focuses on making point-of-care diagnostics widely accessible to combat the global epidemic of liver disease, particularly nonalcoholic fatty liver disease.
Livivos has garnered attention for its potential impact on healthcare, attracting notable investors and medical professionals dedicated to advancing diagnostic technologies. The company has achieved significant milestones, including the successful development and deployment of LiverScope® in various clinical settings. By providing reliable and immediate diagnostic results, Livivos is poised to make a substantial impact on patient outcomes and the broader medical community, enhancing the efficiency and effectiveness of liver disease management.
Companies similar to Livivos include Liv, Avicena, Sapphiros and Vocxi Health.
Livivos was founded in 2018.
Livivos' headquarters is located in San Diego, CA, US.
Livivos' most recent funding round was for $300k (USD) in October 2022.
As of Oct 4, 2022, Livivos has disclosed funding of $300k (USD). Undisclosed round amounts are excluded.
Livivos has 5 employees as of Feb 4, 2024.
